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lators (SERMs) represent principal chemotherapeutic
agents for the treatment and prevention of breast can-
Naoyuki Fujita, David L. Jaye, Masahiro Kajita,
Cissy Geigerman, Carlos S. Moreno,
and Paul A. Wade*
Emory University School of Medicine cers (Sommer and Fuqua, 2001).
Ample evidence links alterations in the homotypic cellDepartment of Pathology and Laboratory Medicine
Whitehead Biomedical Research Building, Room 142 adhesion molecule E-cadherin with the advent of inva-
sive growth in epithelial tumors. E-cadherin function is615 Michael Street
Atlanta, Georgia 30322 required for the production of adherens junctions (Ad-
ams and Nelson, 1998). Both functional disruption of
E-cadherin using monoclonal antibodies (Imhof et al.,
1983) and loss of E-cadherin expression (Behrens et al.,Summary
1989) can disrupt these junctional complexes and elicit
phenotypic changes including the acquisition of inva-Estrogen receptor is a key regulator of proliferation
and differentiation in mammary epithelia and repre- sive growth (Thiery, 2002). While E-cadherin is produced
at normal levels in many well-differentiated tumors, it issents a crucial prognostic indicator and therapeutic
target in breast cancer. Mechanistically, estrogen re- frequently lost during disease progression (Hirohashi,
1998). Downregulation of E-cadherin in tumors is mostceptor induces changes in gene expression through
direct gene activation and also through the biological commonly attributed to epigenetic mechanisms, al-
though occasionally the gene is mutated, leading to afunctions of target loci. Here, we identify the product
of human MTA3 as an estrogen-dependent component nonfunctional protein (Thiery, 2002). The transcription
factors Snail and Slug have been implicated as directof the Mi-2/NuRD transcriptional corepressor in breast
epithelial cells and demonstrate that MTA3 constitutes transcriptional repressors of E-cadherin (Batlle et al.,
2000; Cano et al., 2000; Hajra et al., 2002; Thiery, 2002).a key component of an estrogen-dependent pathway
regulating growth and differentiation. The absence of Moreover, increased Snail expression has been corre-
lated with loss of differentiation and metastasis in breastestrogen receptor or of MTA3 leads to aberrant ex-
pression of the transcriptional repressor Snail, a mas- tumors (Blanco et al., 2002), suggesting that regulation
of Snail may be critical in the maintenance of normalter regulator of epithelial to mesenchymal transitions.
Aberrant Snail expression results in loss of expression epithelial architecture.
The Mi-2/NuRD complex represents a major macro-of the cell adhesion molecule E-cadherin, an event
associated with changes in epithelial architecture and molecular form of histone deacetylase in vertebrates
that was independently isolated in several different labo-invasive growth. These results establish a mechanistic
link between estrogen receptor status and invasive ratories (Tong et al., 1998; Wade et al., 1998; Xue et al.,
1998; Zhang et al., 1998; Humphrey et al., 2001). Thisgrowth of breast cancers.
complex couples a histone deacetylase and nucleo-
some-stimulated ATPase with several subunits of un-Introduction
known function (Wade et al., 1999; Xue et al., 1998;
Zhang et al., 1999). Genetic evidence (Kehle et al., 1998;Estrogen receptors (ER) are members of the superfamily
of nuclear hormone receptors (Mangelsdorf et al., 1998; Ch’ng and Kenyon, 1999; Solari et al., 1999) implicates
the complex in transcriptional repression following re-Tsai and O’Malley, 1994) whose activity is required for
the normal function of the female reproductive system. cruitment by direct interaction with site-specific DNA
binding proteins. A consistent feature is a 70–80 kDaTwo isoforms of estrogen receptor (ER and ER) have
been described. They function as ligand-dependent polypeptide encoded by either MTA1 or MTA2 (Xue et
al., 1998; Wade et al., 1999; Zhang et al., 1999; Humphreytranscriptional activators (McDonnell and Norris, 2002).
The biological functions downstream of ER result from et al., 2001). MTA1 overexpression is associated with
altered expression of direct transcriptional targets as metastatic growth of cell lines in vitro and with invasive
well as secondary effects mediated by biological activi- growth of tumors (Toh et al., 1997). However, the precise
ties of direct targets. In the mammary gland, estrogen function of this subunit is currently unknown.
receptors regulate normal epithelial cell development In this work, we investigated the MTA1 gene family
and differentiation through their well-documented ef- in the context of breast cancer. A member of this family,
fects on transcription (Nilsson et al., 2001; Couse and MTA3, was found to be a component of the Mi-2/NuRD
Korach, 1999). Estradiol acts as a potent mitogen for complex. Expression of MTA3 was tightly linked with
many breast cancer cell lines (Prall et al., 1998), and estrogen action. MTA3 repressed transcription in a his-
approximately 70% of breast carcinomas are ER posi- tone deacetylase-dependent manner, consistent with
tive and estrogen dependent (Masood, 1992). Mechanis- function as a component of the Mi-2/NuRD complex.
tically, estrogen enhances growth by stimulating the G1 We identified the transcription factor Snail as a direct
to S transition (Prall et al., 1998). These mitogenic effects regulatory target of MTA3 action. Experimental manipu-
can be blocked by estrogen antagonists (McDonnell and lation of MTA3 strongly impacted Snail and E-cadherin
levels. These data indicate direct regulation of Snail tran-
scription by MTA3 and identify a regulatory pathway*Correspondence: pwade@emory.edu
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Figure 1. MTA3 Is a Mi-2/NuRD Subunit
(A) Human MTA1, MTA2, and MTA3 were aligned. Conserved sequence motifs (BAH domain, ELM domain, SANT domain and GATA zinc
finger) are indicated. Gaps introduced to optimize the alignment are denoted by an asterisk.
(B) MTA3 was expressed in HEK 293T cells with a FLAG tag. FLAG-MTA3 was immunoprecipitated from nuclear extracts with FLAG M2
antibody. Immunoblots were analyzed with the indicated antibodies.
(C) MTA3 was expressed in HEK 293T cells with a FLAG epitope tag. Immunoprecipitations were performed from nuclear extracts using the
indicated antibodies. Immunoblots were probed with FLAG antibody.
(D) Endogenous MTA3 was immunoprecipitated from MCF7 nuclear extracts and analyzed by immunoblot. The indicated percentage of input
nuclear extract is shown. Immunoblots were probed with antibodies against Mi-2, MBD3, HDAC1, and HDAC2.
(E) Immunoprecipitation of Mi-2/NuRD complex subunits was performed from MCF7 nuclear extracts and analyzed by immunoblot with MTA3
antibodies. The IgG heavy chain is indicated where appropriate. The bottom depicts immunoprecipitations performed on nuclear extracts
from HEK 293T cells transfected with FLAG-tagged MTA1. Immunoprecipitations were performed using MTA2 and MTA3 antibodies and
probed with FLAG antibody.
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downstream of estrogen receptor that contributes to and quantitatively similar to repression driven by the
MeCP2 TRD and by MBD3. Consistent with previousthe maintenance of normal epithelial architecture.
reports (Jones et al., 1998; Nan et al., 1998), transcrip-
tional repression by the TRD domain of MeCP2 wasResults
partially reversed by both TSA and sodium butyrate. In
contrast, repression by MTA3 and by MBD3 was com-MTA3 Is a Component of the Mi-2/NuRD Complex
The Mi-2/NuRD complex has been described in multiple pletely reversed by both inhibitors. We conclude that
MTA3 is a component of the Mi2/NuRD complex andexperimental systems. All forms purified to date contain
an approximately 80 kDa subunit encoded by MTA1 or that this complex likely functions as a negative regulator
of gene expression.MTA2 (Tong et al., 1998; Wade et al., 1999; Xue et al.,
1998; Zhang et al., 1999; Humphrey et al., 2001). Data-
base searches of genomic and EST sequences revealed MTA3 Expression Is Dependent
on Estrogen Actiona third closely related gene, MTA3 (LocusLink ID 57504).
To initiate characterization of MTA3 in humans, we MTA1 was originally isolated by differential display com-
paring breast cancer cell lines with different growthcloned a cDNA by RT-PCR. As predicted, there are two
RNA species transcribed from the MTA3 locus. One properties (Pencil et al., 1993; Toh et al., 1994). To deter-
mine expression patterns of MTA3, Northern and immu-contains a 1548 bp open reading frame encoding a pro-
tein of 515 amino acids (aa), which we named MTA3, noblot analyses were performed. An MTA3 cDNA probe
identified a single abundant transcript of approximatelyand the other includes a 1785 bp open reading frame
encoding a longer protein of 594 aa, which we now term 2.2 kb (Figure 2A). This transcript was differentially ex-
pressed and was abundant only in the ER-positive cellMTA3L (Figure 1A). The two mRNAs differ in their 3
terminal exons and are predicted to produce two highly lines, MCF7 and T47D (Figure 2A). We infer that this
transcript represents MTA3 (not MTA3L) based on size.similar proteins with unique carboxyl termini. The MTA3
protein shares about 80% similarity to human MTA1 and Control probes for MTA2 hybridized to an abundant
transcript of the appropriate size in all cell lines. Immu-MTA2 proteins, containing several conserved sequence
motifs commonly found in chromatin-associated pro- noblot analysis of several breast and endometrial cell
lines also identified a single species of approximatelyteins.
To determine whether MTA3 is a bona fide Mi2/NuRD 60 kDa, closely matching the predicted size of MTA3
(Figure 2B). Like the transcript, MTA3 protein was abun-complex subunit like MTA2 and MTA1, we performed
biochemical analysis. Endogenous Mi-2, MBD3, and dant only in cells expressing estrogen receptor. In this
report, we focus on the function of the readily detectableHDAC1 were detected in MTA3 immune complexes
whether we precipitated exogenously expressed protein isoform, MTA3.
The correlation of MTA3 with estrogen receptor sug-with an epitope tag (Figure 1B) or endogenous MTA3
(Figure 1D). The converse experiment, precipitation of gested that ER might regulate MTA3 expression. Consis-
tent with this notion, steroid depletion led to a declineendogenous Mi-2, MBD3, and HDAC1, coprecipitated
exogenous (Figure 1C) and endogenous MTA3 (Figure in the expression of MTA3, but not -actin (Figure 2C).
As a further demonstration of specificity, we grew the1E). No association between MTA1 and MTA2 or MTA3
was detected in any case (Figures 1D and 1E). We con- endometrial cell line Ishikawa in the presence of tamoxi-
fen, a specific estrogen receptor modulator. Over a pe-cluded that MTA3 is a bona fide component of the Mi-
2/NuRD complex. Our failure to detect MTA1 or MTA2 in riod of 7 days, a gradual decline in MTA3 protein levels
was observed, while actin levels were unaffected (Figureassociation with MTA3 strongly suggests that multiple,
unique forms of the Mi-2/NuRD complex exist that differ 2C). Next, we overexpressed ER in two ER-positive cell
lines, MCF7 and HeLa. ER overexpression led to com-in their MTA family subunit.
The Mi-2/NuRD complex was described as a histone mensurate increases in MTA3 expression levels in both
cell lines (Figure 2D). Finally, we exogenously expresseddeacetylase complex and transcriptional corepressor.
We used a GAL4 tethering experiment to investigate ER in Hs578t cells and observed de novo expression
of MTA3 (Figure 2E). These data firmly demonstrate thethe functional relationship between MTA3 and histone
deacetylation in transcriptional silencing. We examined dependence of MTA3 expression on estrogen action in
cancer cell lines.the effect of an MTA3-GAL4 DNA binding domain fusion
on transcription of a luciferase reporter containing five
GAL4 binding elements (G5) just upstream of the consti- MTA3 Selectively Represses Snail
The analyses of MTA3 expression suggested that thetutively active SNRPN promoter (Figure 1F). GAL4 DBD
fusions with the known Mi-2/NuRD complex subunit MTA3 complex participates in the genetic program initi-
ated by ligand bound ER. We hypothesized that changesMBD3 and with the transcriptional repression domain
(TRD) of MeCP2 served as controls. Levels of transcrip- in epithelial architecture manifested in many ER-nega-
tive breast cancer cell lines might result from a loss oftional repression driven by MTA3 were dose dependent
(F) GAL4 DNA binding domain fusions to MBD3, MTA3, and the MeCP2 TRD were cotransfected with a luciferase reporter construct. Data
are reported as the ratio of activity from GAL4 site containing to GAL4 site-deficient templates (G5/G0 ratio). The ratio obtained on cotransfection
of the GAL4 DNA binding domain alone was arbitrarily assigned a value of 100. Two different amounts of each effector molecule were
transfected, amounts of DNA used are indicated in the Figure for each GAL4 DBD fusion. The cells were treated with HDAC inhibitors as
described in Experimental Procedures.
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Figure 2. MTA3 Biosynthesis Requires Li-
gand Bound Estrogen Receptor
(A) Northern blot of total RNA from the indi-
cated cell lines was hybridized with probes
for MTA2 and MTA3.
(B) Immunoblot of whole cell lysates from the
indicated cell lines probed with antibodies
for MTA3, estrogen receptor , MTA2, and
-actin.
(C) MCF7 and HeLa cells were grown for the
indicated number of days in media stripped of
steroids. Immunoblots were probed for MTA3
and -actin. Ishikawa cells were grown in nor-
mal growth media supplemented with 1 M
tamoxifen for the indicated number of days.
Immunoblots were probed for MTA3 and
-actin.
(D) MCF7 and HeLa cells were transfected
with ER cDNA. Whole-cell lysates were ana-
lyzed for MTA3, ER, and -actin. The growth
media for these experiments (DMEM with
10% FBS) contains sufficient steroids to pro-
vide normal ER function.
(E) Hs578t cells were transfected with an ER
cDNA, using the amounts indicated. Whole-
cell lysates were analyzed for MTA3, ER, and
-actin.
MTA3 function. Recent reports have documented roles crosslinking step using dimethyl 3,3-dithiobispropion-
imidate-2HCl (DTBP). As previously described for thefor the transcription factors Snail and Slug in repression
of the cell adhesion molecule E-cadherin (Batlle et al., histone deacetylase RPD3 (Kurdistani et al., 2002), co-
precipitation of both MTA3 and MBD3 with the Snail2000; Cano et al., 2000; Hajra et al., 2002). As E-cadherin
is crucial to maintenance of normal epithelial cell contact promoter in the ER-positive MCF7 cell line was strongly
enhanced by protein-protein crosslinking with DTBP.(Hajra and Fearon, 2002), we reasoned that Snail and/
or Slug might represent regulatory targets of MTA3. This observation suggests that MTA3 and MBD3, a
known component of the Mi-2/NuRD complex, associ-Therefore, Snail and Slug promoter-luciferase fusions
were constructed and assayed. Cotransfection of either ate with the Snail promoter through interaction with un-
identified DNA binding proteins (Figure 4A). We furtherER or MTA3 repressed transcription from Snail, but
not from Slug, in a dose-dependent manner (Figures 3A characterized this interaction by performing a primer
walk across a genomic region encompassing the Snailand 3B). In contrast, MTA1 had little effect. As controls
for promoter specificity, we analyzed the p16 and cyclin promoter. MTA3 and MBD3 were strongly associated
with genomic DNA immediately upstream of the SnailD1 promoters. None of the protein effector molecules
inhibited p16 or cyclin D1 (Figure 3C and 3D). If MTA3 transcription start site (Figure 4B). As expected from
the reporter assays, we did not detect an interactionfunctions as a component of the Mi-2/NuRD complex,
repression should be sensitive to inhibitors of histone between MTA3 and the Slug promoter.
In the ER-negative Hs578t cell line, neither MTA3 nordeacetylase. Therefore, we asked whether the repres-
sive activities of MTA3 and ER were sensitive to HDAC MBD3 immunoprecipitates contained Snail promoter
DNA (Figure 4C). The MTA3 and MBD3 antisera failedinhibitors (Figure 3E). Repression by both MTA3 and
ER was completely reversed. In aggregate, these data to precipitate negative controls, the G6PD promoter and
the far upstream region of Snail, under any circum-strongly suggest that MTA3 represses Snail in an HDAC-
dependent manner but has no effect on Slug. stances. Consistent with our inability to coprecipitate
MTA2 with MTA3, we did not observe evidence for asso-
ciation of MTA2 with the Snail promoter (Figures 4A–4C).MTA3 Complex Localizes on the Snail Promoter
To determine whether MTA3 physically associates with The negative control rabbit IgG immune complexes also
did not contain Snail DNA. To determine whether experi-the endogenous Snail promoter, we performed a chro-
matin immunoprecipitation assay (ChIP). We compared mental manipulation of MTA3 would result in de novo
association with Snail, we transfected Hs578t with ER.the ability of MTA3 antibodies to precipitate the Snail
promoter in cell lines expressing MTA3 at activated MTA3 immune complexes clearly contained Snail pro-
moter DNA (Figure 4D). Neither control rabbit IgG nor(MCF7) and basal levels (Hs578t). Cells were fixed with
formaldehyde with or without an initial protein-protein anti-ER antibodies precipitated the Snail promoter.
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Figure 3. MTA3-Dependent Transcriptional
Repression of Snail
(A–D) HeLa and HEK 293T cells were trans-
fected with the indicated luciferase reporter
and the effector molecules ER, MTA3, and
MTA1. Luciferase values (normalized) for
mock effector transfections were arbitrarily
assigned a value of 100.
(E) Transfections were performed with the
Snail-luciferase reporter as in (A). The indi-
cated histone deacetylase inhibitors were
added and luciferase activity was determined
as above.
These data demonstrate that MTA3 forms a complex of steroids for 7 days. Subsequently, estradiol was
added, and cells were collected at various time pointscontaining other components of Mi-2/NuRD on the Snail
promoter in an ER-dependent fashion. for RT-PCR. While depletion of steroids led to a dramatic
decline in MTA3 transcript levels, the addition of estra-
diol restored expression to control levels within 2 hrMTA3 Expression Correlates with Snail Repression
and with E-Cadherin Transcription (Figure 4F, black bars). In contrast to MTA3, Snail tran-
script levels were increased in the steroid-depleted me-The ability to manipulate MTA3 through experimental
alterations in estradiol constitutes a valuable tool. The dia. However, the addition of estradiol reverted steady-
state levels of Snail back to control levels (Figure 4F).ER-positive T47D cell line was grown in media depleted
Cell
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Figure 4. MTA3 Is Present on the Repressed Snail Promoter
(A) Chromatin immunoprecipitations (ChIP) were performed on MCF7 chromatin using the indicated antisera. Crosslinking with DTBP preceded
formaldehyde fixation in the indicated lanes. PCR detection of G6PD, the Snail proximal promoter (990 to 3), and Snail far upstream (Snail
[A], approximately 2000) sequences are indicated.
(B) A primer walk was performed across the Snail promoter with DNA precipitated by the indicated antibodies. The diagram indicates the
location of the primer sets. All chromatin was crosslinked with DTBP prior to formaldehyde.
(C) ChIP assay was performed on Hs578t chromatin using the indicated antisera.
(D) ChIP assay was performed on chromatin from Hs578t cells transfected with ER. PCR products from Snail and G6PD are indicated.
(E) ChIP assay was performed on chromatin from MCF7 and Hs578t cells using control rabbit IgG or estrogen receptor antibodies. Detection
of Snail promoter (primer set D) and E-cadherin promoter sequences are depicted. All chromatin was crosslinked with DTBP then formaldehyde.
(F) T47D cells were grown in the absence of steroids for 7 days. At time 0, estradiol was added and cells were collected at the indicated time
points. RT-PCR was performed with real time detection for the indicated mRNAs as described in Experimental Procedures. RNA levels were
determined without (black bars) or with (hatched bars) at 1 hr pretreatment with cycloheximide (25 ng/ml) prior to addition of estradiol at time 0.
Consistent with the identification of Snail as a negative The very rapid reactivation of E-cadherin in these ex-
periments suggested that ER might contribute to itsregulator of E-cadherin, levels of E-cadherin mRNA
closely paralleled those of MTA3 (Figure 4F). This strong transcription. To determine whether estrogen receptor
directly regulated E-cadherin transcription, we againcorrelation between the appearance of MTA3 and the
decline in Snail transcript levels is consistent with a grew T47D in the absence of endogenous steroids and
pretreated cells with cycloheximide to block new proteindirect role for MTA3 in regulation of Snail. Steady-state
levels of Slug were unaltered in this experiment, demon- synthesis prior to the addition of estradiol. RNA was
prepared and analyzed by RT-PCR (Figure 4F, hatchedstrating that Slug expression is independent of estrogen
action. bars). To our surprise, MTA3 mRNA levels failed to re-
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spond to estrogen addition, indicating that estrogen re- ER (Figure 6D) and PR (data not shown) failed to demon-
strate MTA3 immunoreactivity (Figure 6B) and alsoceptor does not directly activate MTA3. As expected,
Snail RNA levels were unaffected by addition of estradiol lacked strong E-cadherin staining (Figure 6F). However,
this case did stain with the anti-MTA2 antibody, whichin the presence of cycloheximide. E-cadherin mRNA
also failed to respond to estrogen addition, indicating demonstrated strong staining in all nuclei, regardless of
cell type, in every case examined (data not shown). Inthat ER does not directly activate its transcription.
addition, we performed immunostaining of MTA3 and
ER in a larger sample of clinical specimens (total 21MTA3 Regulates the Expression of E-Cadherin
cases; see Supplemental Tables S1 and S2 online atThese results suggested that MTA3, Snail, and E-cadh-
http://www.cell.com/cgi/content/full/113/2/207/DC1).erin are components of a pathway downstream of ER.
In these cases, MTA3 expression was strongly corre-Therefore, we tested whether MTA3 was both necessary
lated with ER status (Pearson correlation coefficient ofand sufficient for regulation of E-cadherin. MTA3 was
0.69 with p  0.0013).exogenously expressed in Hs578t (low level ER, MTA3,
To determine whether our observations regardingand E-cadherin). RT-PCR analysis demonstrated that
MTA3 and ER can be extended in clinical samples toSnail mRNA levels declined in response to expression
Snail and E-cadherin, we analyzed a publicly availableof MTA3. E-cadherin transcript was detectable solely
microarray gene expression data set from a study ofwhen MTA3 was overexpressed and not in the mock
115 women (van’t Veer et al., 2002). Analyses were per-transfection control (Figure 5A). This result strongly ar-
formed on the entire dataset of all patients (Figure 7A),gues that MTA3 expression is sufficient for estrogen-
as well as four subsets (Figures 7B–7E). Two of thedependent transcriptional regulation of E-cadherin
subsets, ER positive and ER negative as determinedthrough alterations in Snail levels. To address the re-
by immunohistochemical staining, were provided in thequirement for Snail and for Slug in this system, we uti-
public datasets. The final two patient subsets were sep-lized RNA interference. We designed siRNAs specific
arated based on the gene expression data for MTA3 andfor Snail and for Slug and demonstrated that transfection
divided into MTA3-positive and MTA3-negative subsets,with these siRNAs resulted in decreases in levels of the
respectively. The correlation between ER and MTA3 ex-appropriate mRNA (Figure 5B). Analysis of E-cadherin
pression was statistically significant for the entire pa-transcript levels in this experiment revealed that deple-
tient dataset and for three of the four patient subsetstion of Snail led to increases in E-cadherin mRNA. Like-
analyzed (Figure 7F). The finding that ER and MTA3wise, depletion of Slug led to increased E-cadherin tran-
were not correlated in the ER-positive subset probablyscription (Figure 5C). We concluded that MTA3 regulates
reflects the involvement of intermediary factors down-E-cadherin through alterations in Snail levels. Further-
stream of ER that directly mediate activation of MTA3more, Slug also regulates E-cadherin transcription in an
transcription, as demonstrated in our cycloheximide ex-ER- and MTA3-independent fashion.
periment (Figure 4F). In addition, ER and E-cadherinTo address the necessity for MTA3 in estrogen depen-
expression were positively correlated in all datasets ex-dent expression of E-cadherin, we depleted endoge-
amined, and this was statistically significant for bothnous MTA3 in HeLa and RL-95 cells (Figure 5D). As
the ER-negative and MTA3-negative patient subsetscontrols for RNAi, we used green fluorescent protein
(Figures 7C, 7E, and 7F). A significant negative correla-(GFP) (Elbashir et al., 2001). MTA3 expression was not
tion was observed between ER expression and Snailaffected by GFP siRNA, and MTA3 siRNA did not influ-
expression in the ER-negative patient subset (Figuresence the expression of either MTA2 or -actin (Figure
7C and 7F). Finally, a statistically significant positive5D). However, MTA3 siRNA led to dramatic declines in
correlation was observed between MTA3 and E-cadh-both MTA3 protein and in E-cadherin transcript levels
erin expression for the MTA3 positive patient subsetcompared with controls (buffer or GFP). Snail transcript
(Figure 7F).levels were significantly increased by depletion of MTA3
while Slug was unaffected. We concluded that MTA3 is
both necessary and sufficient for estrogen-dependent Discussion
regulation of E-cadherin transcription and that this regu-
lation is mediated through alterations in Snail levels. Loss of normal tissue architecture is a hallmark event
in disease progression in epithelial cancers. Primary tu-
mors generate cells that invade locally or migrate fromEstrogen Receptor, MTA3, and E-Cadherin Gene
Expression Are Correlated in Breast Cancer Patients the initial site, and invasive growth and metastasis is
estimated to be the root cause of 90% of human cancerImmunohistochemical staining was performed on clini-
cal samples of breast carcinoma to ascertain whether mortality (Sporn, 1996). Cellular changes leading to the
acquisition of invasive growth represent one of the ac-findings in our tissue culture model would be corrobo-
rated in situ. Photomicrographs from two selected cases quired capabilities that define malignant growth (Hana-
han and Weinberg, 2000). Alterations in cell surface ad-are presented in Figure 6. Prominent nuclear MTA3 im-
munoreactivity (Figure 6A) was observed in carcinoma hesion molecules that modulate interactions of epithelial
cells with their tissue microenvironment are likely pre-cells from a case that was positive for estrogen (Figure
6C) and progesterone receptor (data not shown). Stain- requisites for invasive growth. Cell adhesion molecules,
like E-cadherin, constitute an important class of mole-ing of nonepithelial cells is notably absent. E-cadherin
staining of carcinoma cells from the same tumor sample cules that anchor epithelial cells. In addition to physical
attachment, cell adhesion molecules transmit regulatorydemonstrated strong staining at the cellular periphery
(Figure 6E). A separate specimen that was negative for information through cytoplasmic adaptors (Hajra and
Cell
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Figure 5. MTA3 Is Necessary and Sufficient for Estrogen-Dependent Regulation of E-Cadherin Transcription
(A) Hs578t cells were transfected with MTA3 cDNA. The top shows an immunoblot probed with MTA3 antiserum. The bottom depicts RT-
PCR products from the E-cadherin, Snail, Slug, and -actin loci.
(B) RNAi was performed in Hs578t using siRNA for Snail and Slug (see Experimental Procedures). The right depicts RT-PCR products of Snail,
Slug, and -actin following transfection with the indicated siRNAs. The graphs at the right summarize quantitative RT-PCR of the same mRNAs.
(C) cDNAs from Hs578t transfected with Snail and Slug siRNAs were analyzed by RT-PCR for E-cadherin and -actin. The ethidium-stained
gel is depicted alongside quantitation by real time RT-PCR.
(D) RNAi was performed in HeLa and RL-95 cells using the MTA3 siRNA (see Experimental Procedures). Following transfection, whole-cell
lysates were analyzed by immunoblot (see left). The right depicts RT-PCR products from the E-cadherin, Snail, Slug, and -actin loci.
(E) The model depicts the pathway leading from activation of estrogen receptor to transcription of E-cadherin. Details of the model are
discussed in the text.
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Figure 6. Immunoreactivity for MTA3 in Clinical Breast Carcinoma Specimens Is Concordant with Estrogen and Progesterone Receptor
Immunoreactivity
(A) MTA3 was analyzed in a breast carcinoma sample. MTA3 detection is dark brown, nuclei were counterstained with hematoxylin (light blue).
Magnifications is 400 for all images. Asterisks indicate nonepithelial cells.
(B) A second breast carcinoma demonstrating background staining of MTA3.
(C) A serial section of the carcinoma specimen from (A) was analyzed for ER.
(D) A serial section of the carcinoma specimen from (B) was analyzed for ER.
(E) E-cadherin staining in the carcinoma specimen used in (A) and (C).
(F) E-cadherin staining in the carcinoma specimen used in (B) and (D).
Fearon, 2002). Thus, loss of cell adhesion molecules has results now document one pathway regulating tran-
scription of E-cadherin. Loss of function of this pathwaymultiple ramifications on cell physiology. Changes in
E-cadherin abundance or function have been widely ob- occurs in a clinically important subset of breast cancers,
ER-negative carcinomas that have a generally poor clini-served in many different tumor types and are predicted
to contribute to the acquisition of invasive growth (Hana- cal prognosis (Lapidus et al., 1998).
The dependence of MTA3 levels on ER predicts a mech-han and Weinberg, 2000; Hajra and Fearon, 2002). Our
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Figure 7. Microarray Expression Analysis of Breast Cancer Patients Shows Correlations between Estrogen Receptor, MTA3, and E-Cadherin
(A) Hierarchical clustering of gene expression data for ER, MTA3, E-cadherin, and Snail from 115 breast cancer patients. Primary data analyzed
was from van’t Veer et al. (2002).
(B) Hierarchical clustering of the same gene set using the subset of 51 patients that were designated ER positive by immunohistochemistry.
(C) Expression analysis using the data from the subset of 44 patients that were designated ER negative by immunohistochemistry.
(D) Expression analysis of the subset of 44 patients with an MTA3 expression ratio 0.
(E) Expression analysis of the subset of 70 patients with an MTA3 expression ratio 	0.
(F) Graphical representation of the Pearson correlation coefficients of the gene expression patterns shown in (A)–(E). The theoretical maximum
for Pearson correlation coefficients of perfect positive correlation is 
1, and perfect negative correlation is 1. A value of zero represents
no correlation. Statistically significant correlations are marked with an asterisk, and computed p values represent the probability that the null
hypothesis of zero correlation is true.
anism by which receptor status can impact E-cadherin adult life, such a mechanism endows the system with the
ability to respond to biological signals through reversiblebiosynthesis (Figure 5E). ER indirectly activates tran-
scription of MTA3 in response to estrogen signaling. repression of Snail or E-cadherin. Such a strategy im-
parts considerable regulatory potential to a seeminglyMTA3, in turn, forms a transcriptional corepressor com-
plex containing histone deacetylase and ATP-depen- simple event—activation of a ligand-inducible transcrip-
tion factor. Activation of ER leads not only to transcrip-dent chromatin remodeling functions. This complex is
dedicated to gene repression, and one direct target is tional activation, but it also leads to locus specific tran-
scriptional repression through biosynthesis of MTA3.Snail. Thus, ER action indirectly results in transcriptional
repression at Snail. Ultimately, one biological readout The ability to modulate transcription in both a positive
and negative fashion contributes both to the complexityof estrogen signaling through ER is manifested in the
expression of E-cadherin and the maintenance of normal and to the plasticity of the regulatory circuit.
In clinical samples, we observed that loss of ER leads toepithelial architecture. In this manner, ER contributes to
the maintenance of differentiation in breast epithelia. loss of MTA3, expression of Snail, and loss of E-cadherin.
Further, tumors expressing MTA3 also express E-cadh-This pathway utilizes chromatin modifications as a basis
for gene regulation. During female development and erin. These data support the data derived from our cell-
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culture model and strongly suggest that ER is essential pass the requirement for ER-dependent stimulation of cell
for MTA3 expression in mammary epithelium. However, proliferation. Examples include amplification of cyclin
it is also clear from the clinical data that E-cadherin D1, c-myc, and c-ErbB2 (Lapidus et al., 1998). These
transcriptional regulation is complex. We did not ob- genetic alterations produce a cellular state in which ER
serve a statistically significant correlation between ER function is unnecessary for continued growth and prolif-
and MTA3 expression in the microarray data subset of eration. In this paradigm, loss of ER, MTA3, and E-cadh-
ER-positive tumors. This lack of correlation potentially erin expression should provide a selective growth ad-
reflects the involvement of additional factors in the path- vantage in the tumor microenvironment by increasing
way between ER and MTA3. The cycloheximide experi- the probability of invasion and metastasis. Thus, the
ments performed in cultured cells further support the pathway described in this work provides a molecular
existence of such a factor(s). We initially considered the mechanism by which loss of ER expression promotes
progesterone receptor as a prime candidate for direct tumor progression.
regulation of MTA3 transcription, based on the docu-
mented roles of PR in differentiation of mammary epithe-
Experimental Procedures
lia (Couse and Korach, 1999). However, PR antagonists
failed to alter MTA3 RNA or protein levels (data not Cloning of Human MTA3
shown), eliminating PR involvement in MTA3 expression. A tblastn search of the Genbank database using the amino acid
sequence of mouse MTA3 (AF288138) revealed several human ESTFrom these data, we conclude that input to the E-cadh-
clones, including KIAA1266 (XM 038567). The full-length cDNAs forerin promoter comes from many different regulatory cir-
MTA3 were PCR-amplified from HeLa and MCF7 cells. Please seecuits, including the pathway described here.
Supplemental Tables S1 and S2 for PCR primer sequences.We propose that the MTA protein family constitutes
an essential structural component of the Mi-2/NuRD
Cell Culture and Transfectioncomplex. Based on our finding that MTA3 is physically
Cells were cultured in DMEM (Cellgro) with 10% (v/v) fetal bovineassociated with several components of the complex,
serum (Gibco). Steroids were depleted from serum with dextran-but not with MTA1 or MTA2, we predict that each MTA
charcoal (Reddel and Sutherland, 1984). For estrogen depletion,
family member serves as a molecular marker for a dis- cells were grown in phenol red-free RPMI with 10% dextran-char-
tinct subset of a heterogeneous family of complexes. coal-stripped serum and 10 g per ml insulin (Invitrogen). Cells were
We observed that MTA3, but not MTA2, is associated transfected with Lipofectamine (Invitrogen). Transfected cells were
treated with 100 ng/ml trichostatin A and 1 mM sodium n-butyratewith the Snail promoter in ER-positive cells. Further,
(Sigma) for 12 hr where indicated. Luciferase activities were deter-MTA3 supported repression of the Snail promoter in
mined as described (Fujita et al., 2000). Values are the means andtransfection assays where MTA1 did not. These data
standard deviations of the results from three independent experi-strongly support the notion that individual MTA family
ments.
members can impart unique functional properties to the
complex. For instance, MTA1 is reported to repress es-
Plasmidstrogen-dependent transcription through a direct interac-
Human MTA3 and human MTA1 were cloned into pcDNA3 (pcDNA3-tion with ER (Mazumdar et al., 2001). We propose that
MTA3) (Invitrogen). The promoter regions of human p16, Snail, Slug,
MTA2 is a constitutively expressed Mi-2/NuRD subunit Cyclin D1, and SNRPN were amplified from human genomic DNA
and that MTA1 and MTA3 serve specialized functions in and cloned into pGL2-Basic (Promega). Primer sequences are avail-
cell type-specific transcription. In the mammalian SWI/ able in Supplemental Tables S1 and S2. The GAL4 cDNA (amino
acids 1–147) was amplified from pBIND (Promega) and ligated intoSNF complex, subunit composition differs with cell type
pcDNA3. The resulting plasmid was used to make GAL4 DNA binding(Wang et al., 1996), and specific subunits are known to
domain fusions with MTA3, MBD3, and the MeCP2 TRD (aminoimpart functional specificity (Armstrong et al., 1998; Nie
acids 207–310). The fragment containing five GAL4 binding siteset al., 2000). Alternative subunits have the capacity to
from pG5luc (Promega) was inserted into the SNRPN-promoter-
impart unique properties to corepressors and coactiva- containing pGL2-Basic vector.
tors, contributing to cell type-specific patterns of tran-
scription.
Antibodies and Western BlottingEstrogens have long been known to have mitogenic
MTA3 antibodies were generated in rabbits using GST-fused MTA3functions in breast cancer cell lines and in breast tumors
(amino acids 1–147). For affinity purification, MTA3 (1–147) was cou-
(Gruber et al., 2002). Selective estrogen receptor modu- pled to Affi-Gel 15 activated matrix (BioRad). Antibodies were raised
latory compounds (SERMs), which bind directly to ER, against MTA2, Mi2, and MBD3 in rabbits. Other antibodies utilized
can block the growth stimulatory function of estrogens were anti-HDAC1, anti-HDAC2, and anti-ER (Santa Cruz), anti-
-actin (Chemicon), and anti-FLAG (M2) (Sigma).(McDonnell et al., 2002). It is now clear that the receptor
adopts physically unique confirmations when bound to
distinct ligands, providing unique surfaces for interac- Immunoprecipitation
tion of the receptor with coactivators and corepressors Cells were lysed with hypotonic buffer: 0.5% Triton X-100, 10 mM
(McDonnell and Norris, 2002). The regulatory circuit de- Tris (pH 7.5), 10 mM NaCl, 3 mM MgCl2, 0.2 mM PMSF, and 1
scribed in this work has significant implications for mM dithiothreitol (DTT). After centrifugation at 4000 rpm for 2 min,
nuclear pellets were extracted with 10 mM Tris (pH 7.5), 500 mMSERM therapy. Any compound that interferes with the
NaCl, 3 mM MgCl2, 10% glycerol, 1% CHAPS, 0.2 mM PMSF, andability of ER to activate transcription of MTA3 would be
1 mM DTT. After centrifugation, the supernatants were dialyzedpredicted to lead to decreased expression of E-cadherin
versus 10 mM Tris (pH 7.5), 100 mM NaCl, 1 mM MgCl2, 20% glyc-
in breast epithelia and predisposition to invasive growth. erol, 0.2 mM PMSF, and 1 mM DTT. Aliquots of nuclear extract
Approximately 30% of breast carcinomas lack ER ex- (200–400 g) were incubated with specific antibodies or with control
pression. Presumably, these breast cancers become es- IgG (Santa Cruz) for 1 hr at 4C followed by incubation for 1 hr with
25 l of protein G/A agarose (Oncogene).trogen independent through genetic alterations that by-
Cell
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